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Obesity is associated with adipose tissue inflammation, insulin resistance, and the 
development of type 2 diabetes (T2D). However, our knowledge is mostly based on 
conventional murine models and promising preclinical studies rarely translated into suc-
cessful therapies. There is a growing awareness of the limitations of studies in laboratory 
mice, housed in abnormally hygienic specific pathogen-free (SPF) conditions, as relevant 
aspects of the human immune system remain unappreciated. Here, we assessed the 
impact of housing conditions on adaptive immunity and metabolic disease processes 
during high-fat diet (HFD). We therefore compared diet-induced obesity in SPF mice with 
those housed in non-SPF, so-called “antigen exposed” (AE) conditions. Surprisingly, AE 
mice fed a HFD maintained increased insulin levels to compensate for insulin resistance, 
which was reflected in islet hyperplasia and improved glucose tolerance compared 
to SPF mice. By contrast, we observed higher proportions of effector/memory T cell 
subsets in blood and liver of HFD AE mice accompanied by the development of non- 
alcoholic steatohepatitis-like liver pathology. Thus, our data demonstrate the impact of 
housing conditions on metabolic alterations. Studies in AE mice, in which physiological 
microbial exposure was restored, could provide a tool for revealing therapeutic targets 
for immune-based interventions for T2D patients.
Keywords: obesity, adaptive immunity, type 2 diabetes, non-alcoholic steatohepatitis, housing conditions, insulin 
resistance
inTrODUcTiOn
Type 2 diabetes (T2D) is a metabolic disease that is strongly associated with obesity and often 
preceded by insulin resistance. Obesity leads to adipose tissue dysfunction along with triglyceride 
accumulation, adipocyte hypertrophy, adipokine/cytokine secretion, hypoxia, endoplasmic reticu-
lum stress, and impaired mitochondrial function, resulting in the activation of pro-inflammatory 
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processes and adipose tissue fibrosis (1–4). Fibroblasts are also 
accumulated in injured regions from epithelial–mesenchymal 
transition and activated by Th2 immune responses (5). Hypoxia 
associated with adipocyte hypertrophy leads to the activation of 
NFκB-dependent pro-inflammatory responses in adipocytes and 
the expression of alarmin receptors. Necrotic adipocytes release 
cellular contents including alarmin, which has been shown to 
recruit immune cells and induce adipocyte death in turn (6, 7).
Chronic low-grade inflammation of hypertrophic adipose tissue 
plays an etiologic role in the development of insulin resistance (8). 
Obesity and obesity-related complications activate both the innate 
and adaptive arms of the immune system and lead to the recruit-
ment of immune cells in metabolically active organs (9). For a long 
time, research focused on cells of the innate immune system, such as 
macrophages (10, 11), neutrophils (12), eosinophils (13), mast cells 
(14), natural killer cells (15), and dendritic cells (DCs) (16) infiltrat-
ing the visceral adipose tissue (VAT). However, recent data suggest 
the involvement of adaptive immunity, represented particularly 
by T cells (17, 18), showing the complexity of obesity-associated 
intratissue inflammation (19). Altogether, the causal impact of 
inflammation and immune responsiveness as well as the chrono-
logical order of inflammatory events remain largely unknown.
Currently, our understanding of the underlying mechanisms 
in these conditions is mainly based on experiments carried out 
in laboratory mice housed under specific pathogen-free (SPF) 
conditions. Those barrier facilities are unnaturally hygienic and do 
not reflect the microbial diversity humans encounter in their envi-
ronment. Despite success in efficient translation of animal studies 
to the clinic, many murine models failed to translate promising 
treatments of disease models to clinical studies, as relevant aspects 
of the human immune system are unappreciated by SPF mice 
(20, 21). The association between chronic inflammation caused by 
activation of pro-inflammatory targets and cytokines and obesity 
suggest that long-term blockade of those cytokines may be used to 
treat or prevent obesity-induced inflammation. However, even if 
preclinical studies in rodent models of obesity have been promising 
in using such strategies, clinical trials in humans have had mixed 
success. In a recent type 1 diabetes, prevention trial oral insulin was 
given to prediabetic patients based on evidence from animal mod-
els which showed that oral insulin could induce anti-inflammatory 
immune activation to suppress anti-islet responses, however, the 
delayed disease progression was observed only in a subgroup of 
patients (22). Furthermore, another immune-specific clinical 
trial investigating effects of Etanercept in patients with metabolic 
syndrome failed due to such translational difficulties (23).
Recent studies claimed that murine models housed under 
SPF conditions lack effector/memory T cells in contrast to mice 
exposed to antigens, such as pet shop and free-living mice 
(23–25). Thus, chronic exposure to antigens from environmental 
germs under “natural conditions” results in reversed propor-
tions of naïve and effector/memory T cells and a more restricted 
T cell receptor repertoire, associated with changes in the B cell 
and myeloid compartment. This process is called “aging” of the 
adaptive immune system, indicated by increased frequencies of 
effector/memory T cells in blood and immune organs. In con-
trast to naïve and early memory T cells, effector/memory T cells 
express an altered homing and stimulation pattern enabling them 
to infiltrate inflamed tissue sites and contribute to an intratissue 
inflammatory state with major impact on tissue homeostasis. 
Recently, we could establish a model of antigen exposure under 
standardized non-SPF housing conditions (23). Applying this 
model, we investigated the impact of adaptive immunity over 
the course of obesity-related T2D. For this purpose, we analyzed 
the immune cell composition in blood, adipose tissue, and liver 
as well as markers of glucose intolerance and insulin secretion 
in SPF and non-SPF mice [called “antigen exposed” (AE), here], 
receiving normal diet (ND) or high-fat diet (HFD).
MaTerials anD MeThODs
animals and Diet
This study was carried out in accordance with the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of 
Health and the Animal Welfare Act under the supervision of our 
institutional Animal Care and Use Committee. Animal protocols 
were conducted according to institutional ethical guidelines of the 
Charité Berlin, Germany, and were approved by the Landesamt für 
Gesundheit und Soziales (approval number G 0138/14, LAGeSo 
Berlin, Germany) and comply with the ARRIVE guidelines.
Mice were housed in SPF conditions or transferred to the AE 
animal facility at the age of 4 weeks. Table S1 in Supplementary 
Material provides an overview of the specific SPF and AE housing 
conditions. AE housing was complemented with daily non-spe-
cific microbial exposure to antigens from bedding of mammalian 
laboratory animals (sheep and pigs) housed in rooms next to the 
laboratory mice. The exposure was guaranteed by daily handling 
of the laboratory animals and antigens were distributed by air 
passage, as the laboratory staff switched rooms on a regular basis. 
A HFD (60 kJ% from fat, 19 kJ% from proteins, and 21 kJ% from 
carbohydrates, SSNIFF, E15741-34, Soest, Germany) for mice was 
started at 5 weeks of age and continued for either 7 or 15 weeks. 
Age-matched animals were maintained on ND (9 kJ% from fat, 
33 kJ% from proteins, and 58 kJ% from carbohydrates, SSNIFF, 
V1534-300, Soest, Germany). Body weight was followed weekly 
throughout the course of the experiment.
analysis of Metabolic Parameters
Intraperitoneal glucose tolerance test (IPGTT) was performed in 
overnight fasted mice by injecting glucose (1 g/kg body weight; 
B. Braun Melsungen, Melsungen, Germany) and blood glucose 
levels were monitored at 0, 15, 30, 60, and 120 min postglucose 
administration and plotted against time curves to determine the 
glucose tolerance. Serum insulin was measured by ELISA kit using 
a rat insulin standard (Crystal Chem, Downers Grove, IL, USA). 
Body composition was determined by nuclear magnetic reso-
nance using a Bruker Minispec instrument (Bruker, Woodlands, 
TX, USA). Real-time metabolic analyses were conducted using a 
combined indirect calorimetry system (TSE Systems, GmbH, Bad 
Homburg, Germany) as previously described (26).
histological analysis
Following perfusion with saline to minimize contamination 
with cells from the vasculature, liver, and pancreatic tissue were 
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dissected from the surrounding tissues, fixed in formalin, and 
embedded in paraffin. The sections (4 µm) were deparaffinized 
with xylene and rehydrated through an ethanol gradient.
For immunohistochemical (IHC) staining in pancreatic sec-
tions antigen was retrieved by citric acid buffer (pH 6.0) and 
slides were blocked with normal goat serum and incubated with 
anti-insulin antibody (Abcam, Cambridge, UK, 1:200) overnight 
at 4°C. Slides were then washed and incubated with an HRP-
conjugated secondary antibody (Abcam, Cambrige, UK) for 1 h 
at room temperature. After washing in PBS, HRP was visualized 
by NovaRED (VECTOR NovaRED Peroxidase Substrate Kit, 
Vectorlabs, Peterborough, UK) and nuclei were counterstained 
with hematoxylin. Islets were marked by insulin-positive β cells. 
The average islet area and number of islets were calculated per 
total pancreatic area in a minimum of five sections per sample, 
200 µm apart.
Liver was processed for routine hematoxylin/eosin (HE) and 
histochemical staining. Tissue collagen deposition was detected 
by applying the following histochemical staining protocol: 
slides were incubated with a 0.1% Sirius Red solution dissolved 
in saturated picric acid for 1 h washed in acidified water (0.5% 
hydrogen chloride), dehydrated, and mounted with DPX mount-
ing. Collagen and non-collagen components were red- and 
orange-stained. For IHC staining, antigens were unmasked by 
boiling in citrate buffer for 30  min. Slides were blocked using 
0.3% H2O2/H2O for 10 min and incubated overnight with purified 
monoclonal rat IgG2b kappa anti-mouse I-A/I-E (BioLegend, 
Germany, 1:50). Biotinpolyclonal goat anti-rat (1:50) was used 
as second antibody. Slides were then incubated with Avidin-HRP 
(Thermo Fisher Scientific, Germany, 1:2,000) for 30 min. HRP 
was detected with NovaRed (VECTOR NovaRED Peroxidase 
Substrate Kit, Vectorlabs, Peterborough, UK) and slides were 
counterstained with HE.
The slides were analyzed with a Zeiss Axioplan light micro-
scope (Carl Zeiss, Germany) and the images were acquired using 
AxioVert.
Tissue cell Preparation
Mice were sacrificed under anesthesia. For isolation of stromal 
vascular cells, epididymal adipose tissues were removed, minced 
into small pieces and then incubated in a rotational shaker 
(200 rpm) at 37°C for 20 min in collagenase solution (1 mg/ml 
collagenase type 1, Worthington, UK, with 0.5% BSA and 10 mM 
CaCl2 in PBS). The digested tissue was passed through a 100-µm 
mesh and centrifuged (500 g, 10 min). The pellet containing the 
stromal vascular fraction was resuspended with erythrocyte lysis 
buffer (Sigma Aldrich, Germany) and centrifuged (500 g, 5 min). 
Cells were washed again in 2% FCS in PBS, resuspended in 250 µl 
2% FBS in PBS, and counted via trypan blue exclusion. Livers 
were perfused with PBS and minced. Liver mononuclear cells 
were obtained by collagenase digestion of liver tissue for 30 min 
at 37°C on a rotation shaker (200 rpm). Following digestion, the 
cells were centrifuged (30  g, 1  min, RT) to pellet hepatocytes. 
Cells in the supernatant were then centrifuged at (310 g, 4 min, 
4°C) and resuspended in 30% Percoll solution in HBSS followed 
by centrifugation (800 g, 30 min, RT) to enrich liver mononuclear 
cells. Erythrocytes were lysed in 8  ml erythrocyte lysis buffer 
(Sigma Aldrich, Germany) and 2  ml HBSS and centrifuged 
(300 g, 10 min, 4°C). Cell viability was checked with trypan blue 
exclusion.
Flow cytometry
Isolated cells were incubated for FC blocking with CD16/32 
antibody (BioLegend, Germany) for 10  min and antibod-
ies for 20  min, washed twice, and filtered through a 35-µm 
mesh. Antibodies for surface staining are listed in Table S3 in 
Supplementary Material. FACS analysis was performed on a 
BD-LSR Fortessa. FACS data were analyzed by post collection 
compensation using FlowJo 10.0.8 software (Tree Star, Ashland, 
OR, USA).
Participants
Blood samples were collected from a total of 21 obese women 
(body mass index ± SD: 34.61 ± 3.76 kg/m2) included in a study 
focusing on muscle mass regulation “Effects of negative energy 
balance on muscle mass regulation” (registered at https://clinical-
trials.gov, NCT01105143) at the Department of Endocrinology, 
Charité, Berlin.
This study was carried out in accordance with the recom-
mendations of the International Conference on Harmonization 
Guidelines for Good Clinical Practice and the Declaration of 
Helsinki. The protocol of the study was approved by the local 
Ethics Committee of the Charité (EA2/050/10). All subjects gave 
written informed consent in accordance with the Declaration of 
Helsinki before participating in this study.
human antibody Panel
Fluorochrome-conjugated anti-human monoclonal antibodies 
were obtained from Beckman Coulter (Marseille, France) and 
anti-BDCA-2 and anti-BDCA-3 from Miltenyi Biotec (Bergisch 
Gladbach, Germany). Six panel matrices for 7- to 9-fluorochrome 
channels defined and validated by the ONE Study consortium 
were used based on published results (27).
human leukocyte staining
100 µl of anticoagulated peripheral blood cells was stained with 
surface antibodies as previously described (27). All samples were 
measured on 10 color, 3 laser Navios flow cytometers (Beckman 
Coulter), and acquired data were analyzed using the Kaluza 
software, version 1.2 (Beckman Coulter).
statistical analysis
Results are shown as the mean ±  SEM. All analyses were per-
formed using GraphPad Prism, version 6 (GraphPad Software, 
San Diego, CA, USA). P values <0.05 were considered significant. 
Depending on data distribution, Pearson simple coefficient or 
Spearman rank correlation coefficient with two-tailed signifi-
cance test were used for correlation analysis, and Mann–Whitney 
U-test, Student’s t test, or one-way ANOVA followed by Tukey’s 
comparison test were applied to estimate differences between 
groups as appropriate. The body weight, glucose, and insulin time 
course data were analyzed by repeated measurements two-way 
ANOVA followed by Bonferroni post hoc test.
FigUre 1 | Specific pathogen-free (SPF) mice lack effector memory T cell subsets. CD4+ and CD8+ T cell phenotypes were compared between 20 weeks old SPF 
mouse blood (n = 10), 20 weeks old antigen-exposed (AE) mouse blood (n = 10), and adult human blood (n = 21) by fluorescence flow cytometry. Top panels are 
gated on CD3+CD4+ cells and bottom panels are gated on CD3+CD8+ cells and show naïve (CD44−CD62L+/CD45RA+CD62L+), central memory (CD44+CD62L+/
CD45RA−CD62L+), effector memory (CD44+CD62L−/CD45RA−CD62L−), and effector (CD44−CD62L−/CD45RA+CD62L−) T cells. (a) Representative dot plots of 
blood T cell subset distribution in adult human. (B) Representative dot plots of blood T cell subset distribution in SPF and AE mouse. Numbers in panels indicate 
percentages of T cell subsets.
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resUlTs
sPF Mice lack effector Memory  
T cell subsets
To visualize differences in immune responses, we compared T cell 
distribution between SPF, AE mice, and humans. Relative to adult 
humans (Figure  1A), SPF mice showed lower frequencies of 
effector memory (CD44+CD62L−) T cells (<30%), near absence 
of effector (CD44−CD62L−) T cells (<5–10%), and reciprocally, 
higher frequencies of naïve (CD44−CD62L+) T cells (>60%) in 
blood, particularly in the CD8+ T cell compartment (Figure 1B). 
By contrast, decreased proportions of naïve T cells (<40%) and 
enhanced levels of effector memory T cells (>25%) were observed 
in AE mice, which appeared much closer to the human phenotype 
(Figure 1B).
altered immune cell composition  
in ae Mice Kept on hFD
To assess the combined impact of housing conditions and diet on 
the immune composition as well as on the metabolic status, we 
compared AE and SPF mice on HFD and ND. The experimental 
design is shown in Figure 2. All groups were metabolically char-
acterized and blood was analyzed either at week 7 or 15. Similar 
to previous observations, blood from AE mice was enriched in 
effector memory T  cells and, correspondingly, showed lower 
percentages of naïve T cells (both CD4+ and CD8+) compared to 
SPF mice (Figures 3A–C). In addition, a subset of CD44−CD62L− 
T cells strongly increased under AE conditions as an equivalent 
to effector T  cells (Temra) in humans. Remarkably, the frequency 
of effector memory T cells increased further under HFD in AE 
mice, however, not in SPF mice (Figures 3B,C). The significantly 
enhanced expression of PD-1 (CD 279), associated with chronic 
T  cell activation, in AE mice matched these data (Figure  3D). 
Furthermore, the total amount of leukocytes and T cells was higher 
in AE compared to SPF mice (data not shown). Taken together, 
housing conditions and diet have a major impact on T cell subset 
distributions.
Preserved Pancreatic β cell 
responsiveness in hFD ae Mice
To assess the impact of “aged” adaptive immunity following 
antigen exposure on the development of insulin resistance and 
FigUre 2 | Study flowchart. Mice were kept in specific pathogen-free (SPF) conditions or transferred to the non-SPF animal facility at the age of 4 weeks. At the 
age of 6 weeks, male C57Bl/6J mice were fed either a normal diet (ND) or a high-fat diet (HFD) for either 7 or 15 weeks with 10 mice per group. Intraperitoneal 
glucose tolerance test (IPGTT) was performed after 6 or 12 weeks of ND or HFD feeding. Metabolic phenotyping was performed after 11 weeks of ND or HFD 
feeding. Animals were sacrificed at the age of 12 or 20 weeks for sample collection.
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glucose intolerance, we examined the metabolic effects of HFD 
long-term feeding in SPF and AE mice. HFD feeding resulted in 
the development of metabolic alterations already after 7 weeks in 
SPF mice, as shown in Figures S1A–G in Supplementary Material. 
Within both cohorts (SPF and AE), a significant difference in 
body weight between HFD and ND mice was first evident at 
week 4 (P <  0.001) and remained significant throughout the 
following experimental weeks (Figure  4A). HFD-fed AE mice 
tended to gain more weight after 7 weeks and were even signifi-
cantly heavier than their SPF counterparts after 12 weeks of HFD 
feeding. By contrast, epididymal fat pads were enlarged in HFD 
mice but remained unaffected by housing conditions (Figure 4B). 
Whereas glucose tolerance was impaired in HFD mice maintained 
under SPF conditions, surprisingly, the glucose levels of HFD AE 
mice were much lower and did not differ significantly from those 
of the ND AE and SPF mice after 7 weeks (Figure 4C). This strik-
ing difference was not observed at a later time point (15 weeks) in 
HFD-fed mice although fasting and peak glucose levels remained 
slightly lower in AE compared to SPF mice (Figure 4C). Insulin 
levels, measured throughout the IPGTT, were significantly 
higher in HFD AE mice (Figure 4D). The insulinogenic index, 
the ratio of the increment in insulin concentration to the incre-
ment in glucose concentration (ΔI/ΔG) has been proposed as a 
measure for β cell function and is highest in HFD-fed AE mice at 
all time points (Figure 4E). In summary, HFD AE mice develop 
obesity and insulin resistance but show adequate β cell com-
pensation and a delayed development of diabetes in contrast to 
HFD SPF mice.
Diet-induced Obesity rather Than 
housing conditions change the  
immune cell composition in VaT
To further investigate the influence of housing conditions and diet 
on the intra-adipose tissue immune status, we analyzed immune 
cells in the VAT by flow cytometry. Figure 5A summarizes the 
FigUre 3 | Altered immune cell composition in antigen-exposed (AE) mice kept on high-fat diet (HFD). (a) Representative dot plots for CD4+ and CD8+ T cell 
subsets in blood from specific pathogen-free (SPF) and AE mice fed a HFD or normal diet (ND) for 7 weeks. (B,c) Percentages of naïve (CD44−CD62+), central 
memory (CD44+CD62L+), effector memory (CD44+CD62L−), and effector (CD44−CD62L−) CD4+ and CD8+ T cells. Data are represented as mean ± SE.  
Significance was determined using two-way ANOVA multiple measurement. (D) PD-1 expression of CD44+CD62L− T cells in HFD SPF compared to AE mice.  
Data are represented as mean + SE. Significance was determined using unpaired two-sided Mann–Whitney U-test. n = 10 mice per group. *P < 0.05, 
****P < 0.0001.
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relative distribution of various immune cell subsets in HFD AE 
and SPF mice at week 7 (left) and 15 (right) demonstrating a clear 
clustering of the mice in regard to diet.
The percentages of macrophages (F4/80+CD11b+) and DCs 
(CD11b+CD11c+) were significantly higher in HFD compared to 
ND mice, which is in line with previous results (28). However, 
innate immune cells were equivalent between AE and SPF 
groups of mice (Figure 5B). Only some temporary differences in 
dendritic and NK cells were observed between AE and SPF mice 
after 7 weeks of HFD feeding (Figure 5B). Similarly, both HFD 
groups showed comparably decreased proportions of regulatory 
(CD25highCD127−) CD4+ T cells (Treg) and B cells (CD3+B220+) in 
relation to ND mice (Figures 5C,D). Only after 7 weeks, Tregs in 
HFD SPF mice were higher than in ND SPF mice (Figure 5C). As 
expected, in all groups (AE vs. SPF; HFD vs. ND) mainly effector/
memory T cells accumulated in the adipose tissue (Figure 5E). 
Interestingly, at week 7, we could also observe naïve-like and 
central memory T cells in the adipose tissue from AE but not SPF 
mice (Figure 5E). To further assess the impact of metabolic meas-
ures on the systemic immune cell composition, we exploratively 
examined the correlations between body weight, epigonadal 
fat weight, HOMA, and leucocyte cell numbers. Significant 
correlations were found between CD4+ and CD8+ T cell subsets 
as shown in Table S2 in Supplementary Material.
In summary, HFD-fed mice housed in SPF or AE conditions 
display higher levels of distinct innate immune cells compared 
to ND mice, whereas only temporary and minor differences are 
observed between SPF and AE mice.
antigen exposure Protects β cell 
Morphology and Function allowing 
lasting compensation of insulin 
resistance
Next, we examined the histology of the pancreas via HE, IHC 
insulin, and T cell staining to understand the metabolic differ-
ences between the groups. In comparison to ND mice, HFD 
mice developed a small degree of islet hyperplasia as described 
before (29). Furthermore, HFD AE mice showed a higher mean 
cross-sectional area of the pancreatic islets at week 15 compared 
to HFD SPF mice (Figure 6A). Mean islet area was comparable 
in mice under SPF conditions, whereas HFD AE mice tended 
to display a higher mean islet area compared to ND AE mice 
(Figure  6B). However, higher plasma insulin levels did not 
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FigUre 4 | Continued
FigUre 4 | Preserved pancreatic β cell responsiveness in antigen-exposed (AE) high-fat diet (HFD) mice. (a) Weight development in 7-week (w, left) and  
15-week (right) normal diet (ND) and HFD specific pathogen-free (SPF) vs. AE mice. (B) Weight of epididymal fat pads. (c) Intraperitoneal glucose tolerance  
tests were performed in ND and HFD SPF vs. AE mice after 7 weeks (left) and 15 weeks (right) feeding. (D) Circulating insulin levels were assessed before and  
after intraperitoneal glucose injection in ND and HFD SPF vs. AE mice after 7 weeks (left) and 15 weeks (right) feeding. (e) Calculated insulinogenic index,  
n = 10 mice per group. Significance was determined using two-way ANOVA multiple measurement (a,c,D) or using unpaired two-sided Mann–Whitney U-test.  
(B,e) *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. *(HFD SPF vs. ND SPF), ++(HFD AE vs. ND AE), #(HFD SPF vs. HFD AE), <(ND SPF vs. ND AE).
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correlate significantly with the mean islet area (Figure  6C) of 
7 and 15  weeks HFD mice in both the SPF and AE group. In 
the HFD SPF group, grossly diminished numbers of β cells were 
evident, while HFD AE mice showed preserved insulin staining 
(Figure  6D). Notably, periductal pancreatic inflammation was 
neither observed in SPF nor in AE mice. Moreover, immu-
nostaining revealed that almost all CD3+ cells remain in the 
vessels without any alterations between groups (data not shown).
To sum up, histological analyses of pancreatic islets confirm 
increased β cell compensation in AE mice that persisted over the 
observation time of 15 weeks HFD feeding.
hFD in immune-aged Mice is a high risk 
combination for the Development of 
non-alcoholic steatohepatitis (nash)
Obesity is frequently associated with liver steatosis that can 
progress to NASH including a negative predictive value for the 
course of T2D and metabolic syndrome. Therefore, we next 
asked, whether housing conditions would have an impact on 
liver pathology. Intrahepatic naïve CD4+ and CD8+ T cells were 
found to be considerably lower in AE compared to SPF mice at 
week 7 (Figures 7A,B). Conversely, for CD8+ T cells, the fraction 
of effector memory T cells was significantly higher (Figure 7B), 
which was most pronounced in AE mice on HFD. Notably, more 
than 95 and 85% of CD4+ and CD8+ T cells, respectively, expressed 
the effector memory T cell phenotype in AE mice on HFD, a delta 
of >25% compared to SPF mice on HFD (Figures 7A–C). The 
innate cell subsets were less dramatically changed with trends for 
partial replacement of macrophages by infiltrating monocytes in 
AE mice and a slightly enhanced frequency of NK cells in both 
HFD groups (Figure 7D). In addition, SPF mice showed lower 
percentages of immature (MHCIIlow) DCs (Figure 7E) and HFD 
mice displayed higher MHCII antigen expression levels under 
SPF conditions (Figure 7F).
Hematoxylin/eosin staining of liver sections of mice on HFD 
for 15  weeks revealed severe steatosis in AE mice while only 
some SPF mice displayed a mild fat accumulation in the liver. 
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FigUre 5 | Continued
FigUre 5 | Diet-induced obesity rather than housing conditions change the immune cell composition in visceral adipose tissue (VAT). Immune cell composition  
was determined in VAT via flow cytometry in 7 and 15 weeks fed mice. w, weeks. (a) Heatmap showing relative distribution of T cell subsets and cells of the innate 
immune system as percentages of leukocytes in 7 (left) and 15 (right) weeks groups. Red indicates higher proportion and blue indicates lower proportion. cm, 
central memory; em, effector memory. (B) Distribution of innate immune cells as percentage of leukocytes in high-fat diet (HFD) and normal diet (ND) mice 
maintained under specific pathogen-free (SPF) or antigen-exposed (AE) conditions in 7 (left) and 15 (right) week groups. (c,D) Proportion of regulatory T and B cells 
in VAT of SPF or AE mice in 7 (left) and 15 (right) week groups. (e) Percentages of CD44−CD62L+ (naïve), CD44+CD62L+ (central memory), CD44+CD62L+ (effector 
memory), and CD44−CD62L− (probably effector) T cells in 7 (left) and 15 (right) week groups. Significance was determined using two-way ANOVA multiple 
measurement (B,e) or ANOVA followed by Tukey’s multiple comparisons test (c,D) n = 10 mice per group. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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In addition to a strong increase of large lipid droplets result-
ing in macrovesicular steatosis, the livers of AE mice on HFD 
showed lobular inflammation, hepatocyte injury in the form 
of hepatocellular ballooning, and destroyed lobule structure. 
However, livers of ND AE mice did not display any signs of 
NASH (Figure 7G). However, liver weight did not differ between 
all groups (Figure  7H). Blinded NASH scoring of liver histol-
ogy confirmed that 8/8 AE mice on 15 weeks HFD displayed a 
strong NASH phenotype (score > 3–5), whereas NASH was not 
observed in the majority of SPF mice (5/8, score < 1) (Figure 7I). 
The remaining liver sections were categorized as displaying only 
a mild form of NASH (3/8, score = 3) (Figure 7I). Furthermore, 
CD3 staining confirmed lobular inflammation in HFD AE mice 
(Figure 7J, upper row), whereas Sirius Red staining revealed mild 
pericellular fibrosis in those mice (Figure 7J, lower row).
Altogether, AE mice display protected insulin production from 
pancreatic islet cells but develop more severe hepatic steatosis.
DiscUssiOn
We confirm our hypothesis that “aging” of the adaptive immune 
system has a major impact on the course of obesity-related insulin 
resistance. Whereas obesity-induced insulin resistance is rather 
comparable in both groups fed a HFD, AE mice showed improved 
glucose tolerance by preserved compensatory β-cell function 
(protective effect). By contrast, immune aging was associated 
with rapid development of NASH (detrimental effect). The data 
underline the need for novel preclinical models that are closer to 
the human situation.
The prevalence of obesity and T2D is increasing worldwide (30). 
It is widely accepted that adipose tissue inflammation contributes 
to the development of obesity-related insulin resistance (31, 32). 
Various components of both the innate and the adaptive immune 
systems were identified as major players in regulating inflamma-
tory processes in the development of insulin resistance (33–35), 
FigUre 6 | Antigen exposure protects pancreas morphology and function allowing lasting compensation of insulin resistance. Hematoxylin/eosin and 
immunohistochemical (IHC) insulin stainings were performed in 7 and 15 weeks fed mice. (a) Mean islet cross-sectional area expressed as the percentage of the 
total pancreas area in 7 and 15 weeks fed specific pathogen-free (SPF) and antigen-exposed (AE) mice. Grubbs’ analysis identified one outlier in 15 weeks high-fat 
diet (HFD)-fed SPF mice. (B) Mean islet area in mm2 for 7 and 15 weeks fed SPF and AE mice. n = 5–6 mice per group. (c) Mean islet area initially tends to 
correlate with fasting insulin in all groups (P = 0.0004) (left), but correlation decreases over time because fasting insulin levels are kept high in AE mice only, 
P = 0.011 (right). (D) Representative serial sections from mouse pancreas immunostained for insulin. Results are representative of five to six mice.  
Significance was determined using unpaired two-sided Mann–Whitney U-test or one-way ANOVA. Scale bar, 50 µm.
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vasculitis, and remodeling of parenchymal organs (36–38). 
However, knowledge about the exact pathomechanisms driving 
the process across the checkpoints is limited. Recently, awareness 
arose about the limitations of commonly used animal models 
regarding the shortcomings of clinical challenges (39, 40). With 
increasing knowledge about the role of the adaptive immune 
system, in particular of tissue-resident and tissue-infiltrating 
T cells, in controlling tissue homeostasis it is more evident than 
ever that our widely used SPF mouse models do not reflect the 
“aging” immune system as seen in adults (23, 24).
Abnormally hygienic housing conditions of laboratory mice 
may account for limited translational potential to humans. To 
tackle this issue, we applied our recently developed model of AE 
housing and compared the development of insulin resistance, 
glucose tolerance, β-cell function, and liver histology in two 
HFD-fed groups: one kept SPF and the other outside the SPF 
barrier in AE conditions.
Consistently, AE mice expressed a higher proportion of anti-
gen experienced CD4+ and CD8+ T cells. In particular, memory 
effector T cell subsets were increased. Notably, AE mice did not 
acquire infectious diseases, as monitored following FELASA 
guidelines on a regular basis.
Our results demonstrate that changes in the immune cell 
composition of HFD-fed C57BL/6J mice affect the time course of 
glucose intolerance and insulin secretion. Interestingly, in con-
trast to our hypothesis, development of obesity-induced insulin 
resistance was comparable between the two HFD groups. This 
is in line with immune cell subsets in VAT. Even in SPF mice, 
we observed a dominance of effector/memory T  cells in VAT. 
Remarkably, HFD in both groups (SPF and AE) enhanced the 
effector/regulatory T cell ratio resulting in an immune disbalance 
in adipose tissue. We already mentioned that hypoxia associated 
with adipocyte hypertrophy can lead to the activation of NFκB-
dependent pro-inflammatory responses in adipocytes (6, 7). The 
increase of systemic chronic inflammation by antigen exposure 
could further contribute to this hypoxia-dependent pathomecha-
nism and increase the activation of pro-inflammatory cytokines 
in turn.
FigUre 7 | Continued
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Intriguingly, AE mice fed a HFD revealed higher β-cell 
responsiveness that was observed as excess in insulin levels, 
which compensates for glucose intolerance for at least 7 weeks. 
Furthermore, hyperinsulinemia in AE mice was in accordance 
with elevated body weight compared to SPF mice. As expected, 
pancreas histology revealed enlarged islet areas that correlated 
initially with fasting insulin levels in HFD mice. By contrast, 
β cells in SPF mice lost their functionality over time, confirmed 
by decreased insulin secretion and the strong correlation between 
islet mass and fasting insulin levels. Remarkably, β cells from AE 
mice were protected allowing continuous hyperinsulinemia. So 
far, the mechanism behind the protective effect is unclear. The 
number of pancreas infiltrating T cells was roughly equal in both 
groups. Most T cells stuck to the perivascular region and did not 
enter the islets. As the pancreas expresses many IL-22 receptors 
(41), it could be speculated that Th17/22 cells might enter to 
secrete the pro-regenerative, islet-protective cytokine IL-22.
An alternative explanation might be that a vagus and/or sympa-
thetic activation caused by systemic and local inflammation trig-
gers the so-called “anti-inflammatory reflex” in pancreatic islets 
in AE mice, as described recently in critically ill patients suffering 
from major surgery or stroke-induced immunodeficiency (42–44).
Linked to the increasing prevalence of obesity worldwide, 
NASH, the more inflammatory and progressive form of non-
alcoholic fatty liver disease, emerges as a major health burden in 
developed countries (45). NASH is histologically characterized 
by ballooned hepatocytes, lipid accumulation, fibrosis, and peri-
cellular inflammation and may progress to cirrhosis, end stage 
FigUre 7 | High-fat diet (HFD) in immune-aged mice is a high-risk combination for the development of non-alcoholic steatohepatitis (NASH). Immune cell 
composition in livers of 7 weeks fed specific pathogen-free (SPF) and antigen-exposed (AE) mice was analyzed via flow cytometry. (a–c) CD4+ and CD8+ T-cell liver 
phenotypes were compared among 7-week HFD and normal diet (ND) mice maintained under SPF and AE conditions. (D) Percentages of innate immune cells in 
liver tissue. MHCII staining was performed in 15 weeks fed AE mice. (e,F) Percentages of immature (MHClow) dendritic cells in liver tissue and representative 
Immunohistochemical (IHC) staining with MHCII (asterisk) in 15-week HFD and ND AE mice. Hematoxylin/eosin stainings were performed in 15 weeks fed SPF and 
AE mice. (g) Representative staining of ND AE and HFD SPF and AE mice. Infiltration of immune cells (asterisk) and ballooned hepatocytes (arrowhead) illustrate 
NASH. n = 5–10 mice per group. (h) Liver weight of 15 weeks fed mice, n = 10. Significance was determined using one-way ANOVA *P < 0.05. (i) Table showing 
histological scoring system for NASH. (J) IHC staining of CD3-expressing T cells (upper row) and Sirius Red staining (lower row) in paraffin-embedded liver sections 
from mice fed an HFD or ND for 15 weeks. Asterisk indicates CD3 staining, n = 6–10 mice. Significance was determined using two-way ANOVA multiple 
measurement. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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liver disease, or hepatocellular carcinoma (46). Several diets are 
known to induce NASH-like liver pathology in C57BL/6J mice 
(47), but most of these relatively artificial approaches do not 
recapitulate human conditions of NASH and its metabolic con-
sequences. Here, we show for the first time that mice maintained 
under non-SPF “antigen exposed” conditions develop NASH-like 
liver pathology as early as after 7 weeks of HFD feeding. They 
developed macrovesicular steatosis, hepatic infiltration, and 
altered intrahepatic immune cell composition rarely seen in SPF 
mice even after 15 weeks on HFD. Recently, it has been described 
(48) that metabolic activation of intrahepatic immune cells causes 
NASH in C57BL/6J mice in concordance with our results. Thus, 
our study offers a simple mouse model of short-term HFD for 
investigating the development of NASH and the underlying 
mechanisms that also exhibits fidelity to the human condition.
Based on our results, a number of questions arise. First, future 
studies are required to investigate the exact mechanisms of 
T cell activation in the liver and to tackle the question whether 
a systemic immune activation, induced by diet and housing 
conditions, or the dissemination of T cells activated in the liver 
accounts for NASH-like pathology and liver function. In contrast 
to these findings, severe liver inflammation was not accompanied 
by pancreatic tissue inflammation and did not correspond to 
β-cell compensation for insulin resistance. Therefore, further 
studies have to be performed to validate the mechanisms of β cell 
protection, which are currently unknown. Similarly, in patients, 
severe steatohepatitis is often not attended by T2D, even though 
it is assumed that NASH is associated with insulin resistance (49). 
Second, the composition, diversity, and function of the gut micro-
biome was described to be affected by HFDs (50–52), revealing 
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the phenotypes seen in AE mice in a different light. Recently, 
it has been published that gut barrier function, e.g., intestinal 
permeability and alterations in intestinal levels of secondary bile 
acids, depend on housing conditions (53). The question whether 
gut colonization plays a causal role in adipose tissue and liver 
inflammation will be addressed in a forthcoming publication. 
Finally, the influence of food and nutrients composition should 
be considered.
In conclusion, our study identifies an important new 
immunological link between environmental conditions and the 
progression of obesity, insulin resistance, and its comorbidities. 
We provide a new mouse model valuable for revealing new bio-
markers of metabolic disease progression as well as testing novel 
therapeutic approaches.
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